Enrico Giarnieri

Prof. Enrico Giarnieri

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Cancer Letters
Verified
Journal Article
Closed access
MPMaria Elena Pisanu
Maria Elena Pisanu
ANAlessia Noto
Alessia Noto
CVClaudia De Vitis
Claudia De Vitis
SMStefania Morrone
Stefania Morrone
GSGiosuè Scognamiglio
Giosuè Scognamiglio
RMRita Mancini
Rita Mancini

17 July 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ANArianna Di Napoli
Arianna Di Napoli
GPGiuseppina Pepe
Giuseppina Pepe
EGEnrico Giarnieri
Enrico Giarnieri
CCClaudia Cippitelli
Claudia Cippitelli
ABAdriana Bonifacino
Adriana Bonifacino
MGMaria Rosaria Giovagnoli
Maria Rosaria Giovagnoli
Late breast implant seroma may be the presentation of a breast implant-associated anaplastic large cell lymphoma (BI-ALCL), which claims for a prompt recognition. However, BI-ALCL diagnosis on fine-needle aspiration (FNA) might be challenging for pathologists lacking experience with peri-implant breast effusions. Sixty-seven late breast implant seromas collected by FNA from 50 patients were evaluated by Papanicolaou smear stain and immunocytochemistry on cell blocks. A diagnostic algorithm based on the cellular composition, cell morphology and percentage of CD30+ cells was developed. Histological evaluation of the corresponding peri-prosthetic capsules was also performed. Most of the effusions (91% of the samples) were classified as reactive and 9% as BI-ALCL. In the BI-ALCL cases, medium-to-large atypical cells expressing CD30 represented more than 70% of the cellularity, whereas in in the reactive effusions CD30+ elements were extremely rare (<5%) and consisted of non-atypical elements. The reactive effusions were categorized into three patterns: i) acute infiltrate with prominent neutrophilic component (33% of the samples); ii) mixed infiltrate characterized by a variable number of neutrophils, lymphocytes and macrophages (30% of the samples); iii) chronic infiltrate composed predominantly of T lymphocytes or macrophages with only sporadic granulocytes (37% of the samples). The inflammatory cytological patterns were consistent with the histology of the corresponding capsules. Our results indicate that cytological analysis of late breast implant effusions, supported by the knowledge of the heterogeneous cytomorphological spectrum of late seromas, is a valuable approach for the early recognition of BI-ALCL.

18 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRita Mancini
Rita Mancini
EGEnrico Giarnieri
Enrico Giarnieri
CVClaudia De Vitis
Claudia De Vitis
Donatella MalangaDonatella Malanga
Donatella Malanga
GRGiuseppe Roscilli
Giuseppe Roscilli
Gennaro CilibertoGennaro Ciliberto
Gennaro Ciliberto
Malignant pleural effusions (MPEs) could represent an excellent source to culture a wide variety of cancer cells from different donors. In this study, we set up culture conditions for cancer cells deriving from MPEs of several patients affected by the most frequent form of lung cancer, namely the subset of non small cell lung cancers (NSCLC) classified as Lung Adenocarcinomas (AdenoCa) which account for approximately 40% of lung cancer cases. AdenoCa malignant pleural effusions gave rise to in vitro cultures both in adherent and/or in spheroid conditions in almost all cases analyzed. We characterized in greater detail two samples which showed the most efficient propagation in vitro. In these samples we also compared gene profiles of spheroid vs adherent cultures and identified a set of differentially expressed genes. Finally we achieved efficient tumor engraftment in recipient NOD/SCID mice, also upon inoculation of small number of cells, thus suggesting indirectly the presence of tumor initiating cells.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MPMaria Elena Pisanu
Maria Elena Pisanu
ANAlessia Noto
Alessia Noto
CVClaudia De Vitis
Claudia De Vitis
MMMaria Grazia Masiello
Maria Grazia Masiello
PCPierpaolo Coluccia
Pierpaolo Coluccia
RMRita Mancini
Rita Mancini
Microgravity influences cell differentiation by modifying the morphogenetic field in which stem cells are embedded. Preliminary data showed indeed that stem cells are committed to selective differentiation when exposed to real or simulated microgravity. Our study provides evidence that a similar event occurs when cancer stem cells (CSCs) are cultured in microgravity. In the same time, a significant increase in apoptosis was recorded: those data point out that microgravity rescues CSCs from their relative quiescent state, inducing CSCs to lose their stemness features, as documented by the decrease in ALDH and the downregulation of both Nanog and Oct-4 genes. Those traits were stably acquired and preserved by CSCs when cells were placed again on a 1 g field. Studies conducted in microgravity on CSCs may improve our understanding of the fundamental role exerted by biophysical forces in cancer cell growth and function.

1 October 2010 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MTM. La Torre
M. La Torre
MFM. Ferri
M. Ferri
MGM.R. Giovagnoli
M.R. Giovagnoli
NSN. Sforza
N. Sforza
GCG. Cosenza
G. Cosenza
VZV. Ziparo
V. Ziparo

29 February 2016 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
GRGiuseppe Roscilli
Giuseppe Roscilli
CVClaudia De Vitis
Claudia De Vitis
FFFabiana Fosca Ferrara
Fabiana Fosca Ferrara
ANAlessia Noto
Alessia Noto
ECEmanuela Cherubini
Emanuela Cherubini
RMRita Mancini
Rita Mancini
Lung cancer is the leading cause of cancer related deaths and Malignant Pleural Effusion (MPE) is a frequent complication. Current therapies suffer from lack of efficacy in a great percentage of cases, especially when cancer is diagnosed at a late stage. Moreover patients’ responses vary and the outcome is unpredictable. Therefore, the identification of patients who will benefit most of chemotherapy treatment is important for accurate prognostication and better outcome. In this study, using malignant pleural effusions (MPE) from non-small cell lung cancer (NSCLC) patients, we established a collection of patient-derived Adenocarcinoma cultures which were characterized for their sensitivity to chemotherapeutic drugs used in the clinical practice. Tumor cells present in MPEs of patients with NSCLC were isolated by density gradient centrifugation, placed in culture and genotyped by next generation sequencing. In a subset of cases patient derived xenografts (PDX) were obtained upon tumor cell inoculation in rag2/IL2 knock-out mice. Isolated primary cultures were characterized and tested for drug sensitivity by in vitro proliferation assays. Additivity, antagonism or synergy for combinatorial treatments were determined by analysis with the Calcusyn software. We have optimized isolation procedures and culture conditions to expand in vitro primary cultures from Malignant Pleural Effusions (MPEs) of patients affected by lung adenocarcinomas, the most frequent form of non small cell lung cancer. Using this approach we have been able to establish 16 primary cultures from MPEs. Cells were banked at low passages and were characterized for their mutational pattern by next generation sequencing for most common driver mutations in lung cancer. Moreover, amplified cultures were shown to engraft with high efficiency when injected in immunocompromised mice. Cancer cell sensitivity to drugs used in standard chemotherapy regimens was assessed either individually or in combination. Differential chemosensitivity and different mutation profiles were observed which suggests that this isolation method could provide a platform for predicting the efficacy of chemotherapy in the clinical setting. Most importantly for six patients it was possible to establish a correlation between drug response in vitro and response to therapy in the clinic. Results obtained using primary cultured cells from MPEs underscore the heterogeneity of NSCLC in advanced stage as indicated by drug response and mutation profile. Comparison of data obtained from in vitro assays with patients’ responses to therapy leads to the conclusion that this strategy may provide a potentially useful approach for evaluating individual chemosensitivity profile and tailor the therapy accordingly. Furthermore, combining MPE-derived primary cultures with their genomic testing allows to identify patients eligible to trials with novel targeted agents.